Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
1.139
-0.001 (-0.13%)
At close: Feb 6, 2026, 4:00 PM EST
1.130
-0.009 (-0.75%)
After-hours: Feb 6, 2026, 6:25 PM EST
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $29.97 million as of February 6, 2026. Its market cap has decreased by -37.18% in one year.
Market Cap
29.97M
Enterprise Value
25.92M
1-Year Change
-37.18%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.90M to $29.97M, a decrease of -81.14%. That is a compound annual growth rate of -17.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 30.00M | -1.64% |
| Dec 31, 2025 | 30.50M | -38.76% |
| Dec 31, 2024 | 49.80M | 260.87% |
| Dec 29, 2023 | 13.80M | 27.78% |
| Dec 30, 2022 | 10.80M | -78.82% |
| Dec 31, 2021 | 51.00M | 20.57% |
| Dec 31, 2020 | 42.30M | 166.04% |
| Dec 31, 2019 | 15.90M | 28.23% |
| Dec 31, 2018 | 12.40M | -92.01% |
| Dec 29, 2017 | 155.10M | -2.39% |
| Jun 29, 2017 | 158.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyntra Bio | 30.93M |
| Dyadic International | 30.04M |
| Reviva Pharmaceuticals Holdings | 29.80M |
| Barinthus Biotherapeutics | 29.42M |
| Werewolf Therapeutics | 29.42M |
| Hyperion DeFi | 29.06M |
| AN2 Therapeutics | 29.05M |
| Passage Bio | 28.96M |